insights_auto
Why is CTNM up 8,19%?
Dive Deeperchevron_right
CTNM:NASDAQ
Contineum Therapeutics Inc
US$10,30
arrow_upward
+8,19%(+0,78) 1D
US$10,50
arrow_upward
+1,94% (+0,20)bedtimeAfter hours
Closed: 9 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CTNM...
Open
US$9,74
High
US$10,50
Low
US$9,32
Mkt. cap
404,44 ລ້ານ
Avg. vol.
1,14 ລ້ານ
Volume
264,64 ພັນ
52-wk high
US$17,78
52-wk low
US$6,72
EPS
US$-1,77
Shares outstanding
35,35 ລ້ານ
No. of employees
51
Open
US$9,74
High
US$10,50
Low
US$9,32
Mkt. cap
404,44 ລ້ານ
Avg. vol.
1,14 ລ້ານ
Volume
264,64 ພັນ
52-wk high
US$17,78
52-wk low
US$6,72
EPS
US$-1,77
Shares outstanding
35,35 ລ້ານ
No. of employees
51
News stories
From web sources and news partners
Investing.com
·
11 ຊົ່ວໂມງກ່ອນ
Contineum adds Qureight imaging tool to IPF drug trial
About Contineum Therapeutics Inc
CEO-
Employees51
Founded2009
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecontineum-tx.com